The chief justice’s changes to the rules for litigation make suing big business a whole lot harder. By Moshe Z. Marvit.

Lockheed is now lobbying his transition team. By Robert Beckhusen.

How a ruthless network of super-rich ideologues killed choice and destroyed people’s faith in politics. By George Monbiot.

The climax of a standoff with the pharmaceutical industry over high prices. By James Hamblin.

Pop producers back 96 national organizations, defeated 29 proposed regulations. By Beth Mole.

It’s gross, but grossness by itself doesn’t violate securities laws. By Matt Levine. (Aug. 16, 2016)

The EpiPen was invented in the 1970s by a biomedical engineer, Sheldon Kaplan, who was searching for a way to treat allergic reactions quickly. What he came up with was the EpiPen we know today: a pen-like device that delivers a premeasured dose of the hormone epinephrine in emergency situations. The device is ubiquitous in our country, carried by those with asthma or life-threatening allergies.

To whom it may concern: As the CEO of Mylan, maker of the world-famous EpiPen, it gives me great pleasure to address you, via email from an undisclosed location, concerning the pricing of our product. As you may know, my father is a U.S. senator from West Virginia, where the state motto is “Montani semper liberi.” It means “mountaineers...

A growing chorus is calling on the Mylan pharmaceutical company to justify its over 400 percent price hikes on EpiPens.

Martin Shkreli, the infamous face of outrageous drug price hikes, was back in federal court Thursday. Shkreli faces eight criminal counts, including two counts of securities fraud and various conspiracy charges, for allegedly deceiving investors about his disastrous financial performance as a hedge fund portfolio manager. But he won't have to stand trial for at least another year. A federal judge in Brooklyn set a date of June 26, 2017.

"Last week, however, under Assistant Attorney General Renata Hesse (a former Wilson Sonsini attorney -- Google’s law firm), the DOJ announced that, going forward, it intends to interpret the Consent Decrees to require ASCAP and BMI to only issue licenses for songs they control 100%, up-ending decades of custom and practice." By Savan Kotecha. (July 20, 2016)

The complex transactions add up to a meaningful loss of revenue from dividend taxes Danish taxpayers would otherwise get. By Cezary Podkul, Anne Skjerning and Tor Johannesson. (July 12, 2016)

Researchers have found a surprising indication of intelligence. By Jeff Guo.

The charity paid millions in federal stimulus funds to developers shortly after longtime tenants were pushed out. “We are spending federal money to throw low-income New Yorkers out of buildings,” wrote a Habitat whistleblower. By Marcelo Rochabrun.

The drug’s price went from $200 in 2009 to $3,000 today. Doctors and patients want to know why. By April Dembosky.

Three lawyers appointed by the court to help administer the settlement fund were paid, in total, almost $2 million, with one of them making almost half a million dollars for four months of work. By Richard A. Webster.

If you thought B.o.B. and Neil deGrasse Tyson’s Flat Earth raps were the most improbable diss tracks ever, wait until you hear the diss track about pharmaceuticals. Martin Shkreli is the man everyone loves to hate lately. The CEO of Turing Pharmaceuticals raised the price of AIDS drug Daraprim from $13.50 to $750 a pill, and then smirked his way through a congressional hearing about it. He also bought the sole copy of the Wu-Tang Clan’s latest album, Once Upon a Time in Shaolin, for $2 million.

Embattled former pharma CEO Martin Shkreli's legal troubles deepened Tuesday when the poster child for greed was sued for copyright infringement in connection to the $2 million Wu-Tang Clan hip-hop album he bought last year. Shkreli is the founder and former CEO of Turing Pharmaceuticals who became reviled for increasing the price of a life-saving drug by more than 5,000 percent last year. He also faces unrelated federal criminal...

On Sunday, Apple CEO Tim Cook appeared on CBS's 60 Minutes and defended the world's largest corporation's record of sheltering profit overseas to avoid U.S. taxes. Interviewer Charlie Rose questioned Cook if Apple is engaged in, quote-unquote, a sophisticated scheme to pay little or no corporate taxes on $74 billion of revenue overseas. Here's how Cook responded. TIM COOK: That is total political crap. There's no truth behind it. Apple pays every tax dollar we owe.

We should denounce ruthless and wild compradors like Wu-Tang superfan Martin Shkreli, but also understand the cold world in which they operate.